Faes Farma, S.A. 0K9H.IL Stock
Faes Farma, S.A. Price Chart
Faes Farma, S.A. 0K9H.IL Financial and Trading Overview
Faes Farma, S.A. stock price | 3.72 EUR |
Previous Close | 3.33 EUR |
Open | 0 EUR |
Bid | 3.21 EUR x 0 |
Ask | 0 EUR x 0 |
Day's Range | 0 - 0 EUR |
52 Week Range | 0 - 4.29 EUR |
Volume | 68.04K EUR |
Avg. Volume | 40.24K EUR |
Market Cap | 1.04B EUR |
Beta (5Y Monthly) | 0.549425 |
PE Ratio (TTM) | 12.701923 |
EPS (TTM) | 0.28 EUR |
Forward Dividend & Yield | 0.07 (2.16%) |
Ex-Dividend Date | April 12, 2023 |
1y Target Est | N/A |
0K9H.IL Valuation Measures
Enterprise Value | 971.58M EUR |
Trailing P/E | 12.701923 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.2308114 |
Price/Book (mrq) | 1.6815174 |
Enterprise Value/Revenue | 2.082 |
Enterprise Value/EBITDA | 8.138 |
Trading Information
Faes Farma, S.A. Stock Price History
Beta (5Y Monthly) | 0.549425 |
52-Week Change | -11.60% |
S&P500 52-Week Change | 20.43% |
52 Week High | 4.29 EUR |
52 Week Low | 0 EUR |
50-Day Moving Average | 3.28 EUR |
200-Day Moving Average | 3.5 EUR |
0K9H.IL Share Statistics
Avg. Volume (3 month) | 40.24K EUR |
Avg. Daily Volume (10-Days) | 14.98K EUR |
Shares Outstanding | 315.23M |
Float | 283.85M |
Short Ratio | N/A |
% Held by Insiders | 6.78% |
% Held by Institutions | 16.05% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.7531 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 19.40% |
Operating Margin (ttm) | 22.04% |
Gross Margin | 65.70% |
EBITDA Margin | 25.58% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 466.66M EUR |
Revenue Per Share (ttm) | 1.53 EUR |
Quarterly Revenue Growth (yoy) | 4.00% |
Gross Profit (ttm) | 299.16M EUR |
EBITDA | 119.4M EUR |
Net Income Avi to Common (ttm) | 90.55M EUR |
Diluted EPS (ttm) | 0.26 |
Quarterly Earnings Growth (yoy) | 3.69% |
Balance Sheet
Total Cash (mrq) | 84.1M EUR |
Total Cash Per Share (mrq) | 0.28 EUR |
Total Debt (mrq) | 37.04M EUR |
Total Debt/Equity (mrq) | 6.15 EUR |
Current Ratio (mrq) | N/A |
Book Value Per Share (mrq) | 1.964 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Faes Farma, S.A.
Country | United Kingdom |
State | N/A |
City | Leioa |
Address | Avenida AutonomIa 10 |
ZIP | 48940 |
Phone | 34 944 81 83 00 |
Website | https://faesfarma.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 1690 |
Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and markets pharmaceutical products and raw materials in Spain and internationally. The company's products include prescription drugs, generic drugs, over-the-counter (OTC) drugs, food supplements, baby foods, and other health products. It offers Actimag, a magnesium pidolate; Bilaxten, an anti-allergic; Bronquidiazina CR, an anti-infective; Claversal for ulcerative colitis and Crohn's disease; Dezacor, a corticoid; Dolotren, an anti-inflammatory; Dolotren Gel; Dynamogen, an anti-anorexic; Ferroprotina, an anti-anaemic; Hidroferol; Lipofen; Positon for dermatitis; strength builder products, such as Potenciator and Surmenalit; Pruina, a laxative; Robaxisal Compuesto, a muscle relaxant and analgesic; Trausan, a citicoline; Venosmil, a venous vasoprotector; Venosmil Gel; and Yendol, an anti-flu. The company also provides Bilastine, an antihistamine molecule for the treatment of allergic rhino conjunctivitis and urticarial; Calcifediol for bone metabolism; Deflazacort to treat osteoarticular disease; Hidrosmin for venous insufficiency; and Mesalazine to treat digestion problems. In addition, it manufactures and sells animal nutrition and health products. It also exports its products. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.
Q&A For Faes Farma, S.A. Stock
What is a current 0K9H.IL stock price?
Faes Farma, S.A. 0K9H.IL stock price today per share is 3.72 EUR.
How to purchase Faes Farma, S.A. stock?
You can buy 0K9H.IL shares on the IOB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Faes Farma, S.A.?
The stock symbol or ticker of Faes Farma, S.A. is 0K9H.IL.
Which industry does the Faes Farma, S.A. company belong to?
The Faes Farma, S.A. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Faes Farma, S.A. have in circulation?
The max supply of Faes Farma, S.A. shares is 338.39M.
What is Faes Farma, S.A. Price to Earnings Ratio (PE Ratio)?
Faes Farma, S.A. PE Ratio is 13.27678600 now.
What was Faes Farma, S.A. earnings per share over the trailing 12 months (TTM)?
Faes Farma, S.A. EPS is 0.28 EUR over the trailing 12 months.
Which sector does the Faes Farma, S.A. company belong to?
The Faes Farma, S.A. sector is Healthcare.